Legal Opinion on Tianjin Lifeon Pharmaceutical Co., Ltd.'s 2025 Annual General Meeting
To: Tianjin Lifeon Pharmaceutical Co., Ltd.
Tianjin Join & High Law Firm (hereinafter referred to as "the Firm") has been entrusted by Tianjin Lifeon Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") to issue this legal opinion regarding the convening and holding of the Company's 2025 Annual General Meeting (hereinafter referred to as "the Meeting"), in accordance with the "Company Law of the People's Republic of China" (hereinafter referred to as "Company Law"), the "Rules for the General Meetings of Shareholders of Listed Companies" (hereinafter referred to as "Shareholder Meeting Rules"), and other relevant laws, regulations, and normative documents (hereinafter referred to as "Laws and Regulations"), as well as the "Articles of Association of Tianjin Lifeon Pharmaceutical Co., Ltd." (hereinafter referred to as "Articles of Association").
This legal opinion only expresses opinions on whether the convening and holding procedures of the Meeting, the qualifications of attendees, the qualifications of the convener, and the voting procedures comply with the relevant laws, regulations, and the Articles of Association. It does not express opinions on the truthfulness, accuracy, or legality of the content of the proposals deliberated at the Meeting or the facts stated in these proposals.
To issue this legal opinion, the Firm's lawyers have reviewed the relevant documents and materials of the Meeting and conducted necessary verification and validation of the convening, holding, and voting procedures, and the qualifications of attendees.
In the process of reviewing the documents provided by the Company, the Firm assumes that: all signatures, seals, and stamps on the documents provided to the Firm are authentic; all original documents submitted are true, accurate, and complete; all facts stated in the documents provided to the Firm are true, accurate, and complete; the signatories of the documents provided to the Firm have full civil capacity and their signatures are duly and effectively authorized; and all copies submitted are identical to their originals, and these originals are true, complete, and accurate.
This legal opinion is for the sole use of the Company for the purpose of this Meeting. Without the prior written consent of the Firm, the Company and any other legal person, unincorporated organization, or individual shall not rely on, use, or cite this legal opinion for any other purpose. The Firm agrees that this legal opinion will be disclosed to the public as part of the announcement materials for this Meeting and will bear relevant legal responsibilities in accordance with the law.
In accordance with the generally accepted professional standards, ethical norms, and the spirit of diligence and responsibility of the legal profession, the Firm provides the following opinions on the legal issues related to the convening and holding procedures, the qualifications of attendees, the voting procedures, and the validity of the votes of the Company's Meeting:
I. Convening Procedures of the Meeting
On March 26, 2026, the Company published a notice of the convening of this Meeting on the information disclosure media designated by the China Securities Regulatory Commission. The notice announced the convener, method of convening, time, place, matters to be deliberated, registration method, and voting method for the Company's 2025 Annual General Meeting.
Upon verification, the Firm's lawyers are of the opinion that the convening procedures of this Meeting comply with the relevant laws, regulations, and the Articles of Association.
II. Holding Procedures of the Meeting
(1) This Meeting was held using a combination of on-site voting and online voting.
(2) The on-site meeting was held as scheduled at 2:45 PM on April 15, 2026, in the conference room of Tianjin Lifeon Pharmaceutical Co., Ltd., located at No. 16 Saida North Road, Xiqing Economic and Technological Development Zone, Tianjin. The time and place of the on-site meeting were consistent with the notice of the Meeting.